Got a headache? Take two tylenol and have a nap. --this conversation takes place regularly in hospitals, physician offices, and even homes. People associate acetominophen (brand name tylenol) with a safe and effective way to relieve pain. However, the FDA has called into
question the safety of this compound and has created a panel which is set to vote today on the future of this pain reliever.
Any increased regulation of acetominophen and acetominophen-containing compounds will likely result in scorn from people already unhappy with the Obama Administration. After all, this president's administration has already lived up to the liberal stereotype of
big brother- labeling its enemies (conservatives) terrorists, taking over private companies, massive government oversight, and so on. Increasing regulation on a drug currently sold without restriction will not help to deviate from this
big brother image. How exactly might the FDA consider regulation of acetominophen? Will it simply make the drug makers change drug dosing guidelines, or are we looking at the moving of acetominophen products behind the counter--prescription only, or will it go to the extreme and pull tylenol altogether? Then the ultimate question: does America need such regulation?
Like all drugs, acetominophen has its side effects, most usually from an abnormal reaction. But one very serious side effect is
liver damage, usually from an overdose of acetominophen (not typically when taking it as prescribed). Healthcare professionals have known this for years and even have a way of treating acetominophen overdose:
acetylcysteine. The efficacy of this antidote depends on numerous factors, including the amount of acetominophen taken and the time between drug ingestion and acetylcysteine administration. To date, acetominophen is the number one cause of
liver failure, which can cause death. To compound the situation, many other drugs either contain acetominophen, such as cough syrups and other painkillers, or interact so as to increase its toxic side effects, such as alcohol. Take home point: know what you are putting into your body!
In a
letter released yesterday, the makers of tylenol suggested that they increase a campaign to educate the public on acetominophen. But it ultimately boils down to the consumer. If the consumer will not educate himself on this drug, and apparently misses or ignores the current education campaign, then does he need the FDA to step in to ensure hia safety? We generally don't need big brother in the private sector, but this might be situation where the benefits of regulation far exceed any possible detriment.